Borah BJ
No ORCID on file
· 12 papers in corpus
· active 2013-2026
Study types
- article 1
Condition tags
- endometriosis 1
- chronic_pelvic_pain 1
- infertility 1
Top journals
Frequent coauthors
2026
Uterine fibroids (leiomyomas or myomas) are a major issue for individuals with a uterus as well as a disease with profound disparities for Black/African American (Black) individuals. These disparities have roots in early gynecologic practic…
2019
BackgroundUterine leiomyomas (fibroid tumors) cause considerable symptoms in 30-50% of women and are the leading cause of hysterectomy in the United States. Women with uterine fibroid tumors often seek uterine-preserving treatments, but com…
2019
ObjectiveTo compare short-term health-related quality of life (HRQOL) 6-12 weeks after hysterectomy or myomectomy for the treatment of symptomatic leiomyomas.MethodsWe conducted a prospective comparative effectiveness analysis of data. In a…
2018
BackgroundUterine fibroids are common in premenopausal women, yet comparative effectiveness research on uterine fibroid treatments is rare.ObjectiveThe purpose of this study was to design and establish a uterine fibroid registry based in th…
2017
ObjectiveTo compare risk of reintervention, long-term clinical outcomes, and health care utilization among women who have bulk symptoms from leiomyoma and who underwent the following procedures: hysterectomy, myomectomy, uterine artery embo…
2017
ObjectivesTo report patterns and patient characteristics associated with initiation of and persistence with medical therapies for uterine fibroid-related heavy menstrual bleeding.DesignRetrospective cohort study.SettingUS commercial insuran…
2017
BackgroundUterine fibroids are a common problem for reproductive-aged women, yet little comparative effectiveness research is available to guide treatment choice. Uterine artery embolization and magnetic resonance imaging-guided focused ult…
2016
BackgroundUterine fibroids are an important source of morbidity for reproductive-aged women. Despite an increasing number of alternatives, hysterectomies account for about 75% of all fibroid interventional treatments. Evidence is lacking to…
article
2015
OBJECTIVE: To analyze the association between patient characteristics and the probability of undergoing any uterine-sparing procedure (endometrial ablation, myomectomy, and uterine artery embolization) compared with hysterectomy as the firs…
2014
BackgroundTo compare one-year all-cause and uterine fibroid (UF)-related direct costs in patients treated with one of the following three uterine-sparing procedures: magnetic resonance-guided focused ultrasound (MRgFUS), uterine artery embo…
2013
BackgroundMagnetic resonance-guided focused ultrasound (MRgFUS) is a relatively new minimally invasive treatment, approved by the US Food and Drug Administration in 2004 for treatments of symptomatic uterine leiomyomas (fibroids). The purpo…
2013
ObjectiveWe sought to characterize the impact of uterine leiomyomas (fibroids) in a racially diverse sample of women in the United States.Study designA total of 968 women (573 white, 268 African American, 127 other races) aged 29-59 years w…